全文获取类型
收费全文 | 1636篇 |
免费 | 640篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 56篇 |
儿科学 | 67篇 |
妇产科学 | 24篇 |
基础医学 | 22篇 |
口腔科学 | 11篇 |
临床医学 | 315篇 |
内科学 | 487篇 |
皮肤病学 | 70篇 |
神经病学 | 138篇 |
特种医学 | 53篇 |
外科学 | 676篇 |
综合类 | 1篇 |
预防医学 | 137篇 |
眼科学 | 121篇 |
药学 | 15篇 |
肿瘤学 | 124篇 |
出版年
2024年 | 17篇 |
2023年 | 200篇 |
2022年 | 19篇 |
2021年 | 67篇 |
2020年 | 95篇 |
2019年 | 33篇 |
2018年 | 173篇 |
2017年 | 174篇 |
2016年 | 158篇 |
2015年 | 144篇 |
2014年 | 196篇 |
2013年 | 192篇 |
2012年 | 66篇 |
2011年 | 58篇 |
2010年 | 141篇 |
2009年 | 182篇 |
2008年 | 58篇 |
2007年 | 17篇 |
2006年 | 47篇 |
2005年 | 25篇 |
2004年 | 14篇 |
2003年 | 7篇 |
2002年 | 11篇 |
2001年 | 23篇 |
2000年 | 9篇 |
1999年 | 22篇 |
1998年 | 27篇 |
1997年 | 25篇 |
1996年 | 25篇 |
1995年 | 23篇 |
1994年 | 11篇 |
1993年 | 11篇 |
1992年 | 9篇 |
1991年 | 8篇 |
1990年 | 5篇 |
1989年 | 3篇 |
1988年 | 3篇 |
1987年 | 4篇 |
1986年 | 2篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1981年 | 4篇 |
1980年 | 2篇 |
1974年 | 2篇 |
1973年 | 1篇 |
1962年 | 1篇 |
排序方式: 共有2317条查询结果,搜索用时 0 毫秒
101.
Torben K. Becker MD Bhakti Hansoti MBChB MPH Susan Bartels MD MPH Mark Bisanzo MD Gabrielle A. Jacquet MD MPH Kevin Lunney MD PhD Regan Marsh MD MPH Maxwell Osei‐Ampofo MBChB MBA MPH Indi Trehan MD MPH Christopher Lam BA Adam C. Levine MD MPH the Global Emergency Medicine Literature Review Group 《Academic emergency medicine》2016,23(10):1183-1191
102.
The Potential Use of Ultrasound‐Magnetic Resonance Imaging Fusion Applications in Musculoskeletal Intervention 下载免费PDF全文
Christopher J. Burke MBChB Jenny Bencardino MD Ronald Adler MD PhD 《Journal of ultrasound in medicine》2017,36(1):217-224
We sought to assess the potential use of an application allowing real‐time ultrasound spatial registration with previously acquired magnetic resonance imaging in musculoskeletal procedures. The ultrasound fusion application was used to perform a range of outpatient procedures including piriformis, sacroiliac joint, pudendal and intercostal nerve perineurial injections, hamstring‐origin calcific tendonopathy barbotage, and 2 soft tissue biopsies at our institution in 2015. The application was used in a total of 7 procedures in 7 patients, all of which were technically successful. The ages of patients ranged from 19 to 86 years. Particular use of the fusion application compared to sonography alone was noted in the biopsy of certain soft tissue lesions and in perineurial therapeutic injections. 相似文献
103.
Native myocardial longitudinal (T1) relaxation time: Regional,age, and sex associations in the healthy adult heart 下载免费PDF全文
104.
Hamady ZZ Malik HZ Finch R Adair R Al-Mukhtar A Prasad KR Toogood GJ Lodge JP 《Annals of surgical oncology》2006,13(11):1493-1499
Background Many colorectal liver metastasis patients are denied surgical resection on the basis of tumour size. The aim of this study was to explore the impact of metastasis size on modern liver resection.Methods Using a prospectively collected database, this was a retrospective analysis of 484 consecutive patients who underwent liver resection for colorectal liver metastases between 1993 and 2003. The cohort was divided into two groups: smaller metastases (<8 cm) and larger metastases (≥ 8 cm). Those with larger metastases were then further stratified into big metastases (8–12 cm) and giant metastases (>12 cm). Demographic, pathological, surgical technique and outcome data were compared between the groups.Results There were 88 (18%) patients with metastases measuring 8 cm or larger. There was an association between higher carcinoembryonic antigen (CEA) and cancer antigen (CA) 19-9 levels and larger metastases. The actuarial 5-year survival for patients with larger metastases was 38% compared with 42% for smaller metastases (not statistically significant). Patients with giant metastases had poorer overall and disease-free survival (both nonsignificant) compared with those with big metastases: 29% and 28% at 5 years, respectively.Conclusion Patients with colorectal liver metastasis greater than 8 cm and up to 12 cm in size should not be treated differently from those with smaller lesions. 相似文献
105.
106.
Parotid metastatic disease from cutaneous squamous cell carcinoma: Prognostic role of facial nerve sacrifice,lateral temporal bone resection,immune status and P‐stage 下载免费PDF全文
107.
Martijnse IS Dudink RL Kusters M Vermeer TA West NP Nieuwenhuijzen GA van Lijnschoten I Martijn H Creemers GJ Lemmens VE van de Velde CJ Sebag-Montefiore D Glynne-Jones R Quirke P Rutten HJ 《Annals of surgical oncology》2012,19(2):392-401
Background
To achieve T-downstaging and better resectability in locally advanced rectal cancer, neoadjuvant radiochemotherapy (RCT) has become the current standard of treatment. A variety of schemes have been used. This study investigates which scheme had the best effect on these parameters.Methods
Our institution is a referral center for locally advanced rectal cancer. Different neoadjuvant radiochemotherapy regimens were administered: long course radiotherapy (RTH), 5-FU and leucovorin (5FUBolus), a combination of capecitabine and oxaliplatin (CORE), and capecitabine only (CAP). Selection of patients for 1 of the regimens was based on hospital policy rather than patient or tumor characteristics.Results
The data of 504 consecutive patients (n?=?181 T3+, n?=?323 T4) without metastatic disease (cM0) who underwent surgery for advanced rectal carcinoma between 1994 and 2010 were reviewed. The RTH, 5FUBolus, CORE, and CAP scheme were administered to 106, 137, 155, and 106 patients, respectively. Odds ratios for downstaging were less effective for RTH, 5FUBolus, and CAP (0.31, 0.44, and 0.31; P?.0001) when compared with the CORE scheme. Odds ratios for a R1 resection (3.74, 1.94, 1.14; P?=?.003) or CRM+ resection (3.78, 2.73, 1.34; P?=?.001) were also in favor of the CORE. Hazard ratios for CSS were significantly better for the CORE scheme.Conclusions
Downstaging with neoadjuvant treatment results in an increased number of radical resections. In our study, the combination of capecitabine and oxaliplatin appears to be the most effective regimen for locally advanced rectal cancer tumors. However, longer follow-up will be necessary to confirm this conclusion. 相似文献108.
109.
110.